SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001400482-14-000037
Filing Date
2014-08-14
Accepted
2014-08-13 19:36:52
Documents
11
Period of Report
2014-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q acucela-20140630xform10q.htm 10-Q 708411
2 CERTIFICATION acucela-20140630xexhibit311.htm EX-31.1 10547
3 CERTIFICATION acucela-20140630xexhibit312.htm EX-31.2 10549
4 CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER acucela-20140630xexhibit321.htm EX-32.1 6025
5 CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER acucela-20140630xexhibit322.htm EX-32.2 5924
  Complete submission text file 0001400482-14-000037.txt   3718956

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT acuc-20140630.xml EX-101.INS 446190
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT acuc-20140630.xsd EX-101.SCH 22947
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT acuc-20140630_cal.xml EX-101.CAL 48038
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT acuc-20140630_def.xml EX-101.DEF 130124
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT acuc-20140630_lab.xml EX-101.LAB 326780
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT acuc-20140630_pre.xml EX-101.PRE 205061
Mailing Address 1301 SECOND AVE. SUITE 1900 SEATTLE WA 98101
Business Address 1301 SECOND AVE. SUITE 1900 SEATTLE WA 98101 206-805-8300
ACUCELA INC. (Filer) CIK: 0001400482 (see all company filings)

IRS No.: 020592619 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-55133 | Film No.: 141039021
SIC: 2834 Pharmaceutical Preparations